back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-12 23:05 Tx date 2024-04-05 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+170,732 vol |
682,982 | |
| Filed 2024-04-12 23:04 Tx date 2024-04-01 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+29,392 vol |
512,250 | |
| Filed 2024-01-08 13:28 Tx date 2024-01-03 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+24,700 vol |
482,858 | |
| Filed 2023-10-06 11:41 Tx date 2023-10-02 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+35,735 vol |
458,158 | |
| Filed 2023-07-06 11:55 Tx date 2023-07-03 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+38,538 vol |
422,423 | |
| Filed 2023-05-10 21:49 Tx date 2023-05-05 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+274,510 vol |
383,885 | |
| Filed 2023-05-10 21:49 Tx date 2022-02-28 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+109,375 vol |
109,375 | |
| Filed 2023-05-10 21:48 Tx date 2021-06-03 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-23 15:39 Tx date 2022-06-22 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+560,000 vol |
5,409,748 | |
| Filed 2022-03-10 14:10 Tx date 2022-02-28 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,304
+200,952 vol $0.32 each |
300,952 | |
| Filed 2021-11-15 14:21 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+655,500 vol |
4,849,748 | |
| Filed 2021-07-30 13:20 Tx date 2021-06-22 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,000
+100,000 vol $0.44 each |
100,000 | |
| Filed 2021-07-30 13:15 Tx date 2021-06-03 |
$EDT
Spectral Medical Inc. |
D'Alvise, Janelle
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-04-01 15:38 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,335,000 vol |
4,194,248 | |
| Filed 2019-04-15 13:55 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,277,440
+998,000 vol $1.28 each |
2,859,248 | |
| Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+906,248 vol |
1,861,248 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$456,660
+258,000 vol $1.77 each |
783,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$761,100
+430,000 vol $1.77 each |
||
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$304,440
+172,000 vol $1.77 each |
1,127,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$761,100
+430,000 vol $1.77 each |
955,000 | |
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+26,250 vol |
26,250 | |
| Filed 2017-02-27 Tx date 2016-05-12 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-22 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$76,125
+52,500 vol $1.45 each |
52,500 | |
| Filed 2016-05-18 Tx date 2016-05-12 |
$APO
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$819,000
+525,000 vol $1.56 each |
525,000 | |
| Filed 2016-05-18 Tx date 2016-05-12 |
$APO
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-18 Tx date 2016-05-12 |
$APO
Acasti Pharma Inc. |
D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|